Formation Pediatrie

XVI Latin American Congress of Pediatrics, ALAPE 2012

The Latin American Association of Pediatrics – ALAPE, welcomes you to its most important international event, the XVI Latin American Congress of Pediatrics.

Latin American Congress of Pediatrics, ALAPE epresents and promotes the voice of pediatricians and children in the region.



Annual Meeting of the Pediatric Academic Societies 2013

The Pediatric Academic Societies (PAS) are four individual pediatric organizations (the American Pediatric Society, Society for Pediatric Research, Academic Pediatric Association and the American Academy of Pediatrics) who together co-sponsor the PAS Annual Meeting. Members of these organizations are pediatricians and other health care providers who are in the research and academic arena, execute research and provide clinical care to pediatric patients. The combined membership of PAS represents all interests in pediatrics including specialists, generalists and community practitioners. The four sponsoring organizations are leaders in the advancement of pediatric research and child advocacy within pediatrics, and all share a mission of fostering the health and well being of children worldwide.

Exhibit at PAS and reach more than 6,100 pediatric health care providers, giving you the opportunity to meet the decision makers from major medical schools, teaching hospitals and private practice.

Connect with the largest gathering of leaders in pediatrics as they come to educate themselves on the latest clinical and basic research finds in pediatrics.



Diplôme Universitaire "Hypnothérapie"



Acquérir une formation complète et de qualité à la pratique de l’hypnose, particulièrement dans le domaine de la psychothérapie (hypnothérapie) Apporter aux praticiens des connaissances scientifiques précises sur les phénomènes mis en jeu en hypnose et ses modalités d’action Transmettre des compétences dévaluation et de modalité d’intervention hypnothérapeutique selon le type de trouble présenté  




MODULE 1 - 28h

1- Technique et méthode hypnotique 2- De la recherche à la clinique

MODULE 2 - 14h 

1- La dépendance 2- Les addictions

MODULE 3 - 14h

1- Les troubles anxieux 
2- la perte et la dépression

MODULE 4 - 14h

1- La psychosomatique 
2- Etats dissociatifs

MODULE 5 - 14h

1- Douleur aiguë
 2- Douleur chronique

MODULE 6 - 14h

1-Le trans-générationnel 
2- La sexothérapie

MODULE 7 - 21h

Etudes de cas / Supervision

MODULE 8 - 7h 

Conférenciers invités

MODULE 9- 14h 

1- Mémoire 
2- Soutenance théorico-clinique


Joint EFGCP / DIA / EMA Medicines for Children Conference onDevelopment of Paediatric Medicines: From Learning to Adapting


The EU paediatric regulation has now been in force since 2007 and has considerably changed the place of paediatric drug development in the general drug development process. Drug development is no longer possible without considering children. The aim of this conference is to discuss on a high level where we stand with paediatric drug development in Europe, where the partners in drug development, i.e. clinicians, industry, regulators and others, agree and where they disagree, in which area the EU regulation can be considered a success, where the regulation might be modified in the future, where and how its daily interpretation by the EMA will be modified, and where collaboration between the involved players can be improved.

The EFGCP / DIA / EMA Paediatric Conference allows an open discussion between academics, clinicians, regulatory authorities, parents’ & patients’ associations and pharmaceutical industry about paediatric drug development. The conference is an annual event that goes back to two series of annual conferences: a first one initiated in 2005 by EFGCP, and a second one initiated in 2007 by DIA. Both were organised in tight collaboration with the EMEA, which in 2011 changed its name to EMA. Since 2010 the two conference series have been merged, and since 2011 EMA is officially co-producing the conference as an equal partner.

The EU paediatric regulation has transformed paediatric drug development from a topic discussed by a handful of interested paediatricians, clinical pharmacologists and regulators to an issue that is broadly known within pharmaceutical industry, regulatory authorities, the clinical world and other institutions. More than 1000 PIPs have so far been submitted, and virtually everybody within pharmaceutical industry has heard of the PIP requirement.

The level of detail in the key elements of Paediatric Investigation Plan has been continuously discussed since the Paediatric Regulation came into force. In the 2011 conference, EMA announced that changes will come in this area; this year EMA will announce how these changes will look like.

As in previous conferences, representatives from all stakeholders will give presentations, and on day 1, participants will have the choice between three breakout sessions to discuss specific issues in smaller groups. This will allow participants to exchange on eye level and face-to-face with their respective counterparts who otherwise interact predominantly by phone and only occasionally at face-to-face meetings.


DIU Douleur de l'enfant en pratique quotidienne


Co-organisation par les unités douleur des hôpitaux Armand Trousseau et Bicêtre

Formation sur 1 an, avec :

12 journées de formation (96 heures d’enseignement) Des ateliers pratiques 5 journées de formation pratique : stage au sein d’unités douleur pédiatriques 2 journées de présentation des projets professionnels de chaque étudiant Validation : contrôle continu des connaissances, assiduité, réalisation d’un projet professionnel sur la douleur de l’enfant.


acquérir les notions indispensables pour reconnaître et traiter la douleur des enfants 



Comité d'organisation

Comité scientifique

unités douleur des hôpitaux Armand Trousseau et Bicêtre

Dr Fournier-Charrière, Dr Annequin, Dr Tourniaire, Mme Lombart

Congres Biologie

Dentaire Soin

Congres Veterinaire

Congres Psychiatrie

Formation Psychiatrie